Locally Advanced Malignant Solid Neoplasm clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages 18 years and up
This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have spread to other places in the body. Adavosertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Sacramento, California and other locations